Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Drug Resistance

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    June 2021
  1. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    PubMed     Abstract available

    February 2021
  2. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    PubMed     Abstract available

  3. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    PubMed     Abstract available

  4. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    PubMed     Abstract available

    December 2020
  5. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    PubMed     Abstract available

    November 2020
  6. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.

    October 2020
  7. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    PubMed     Abstract available

  8. BENNETT SJ, Chunda-Liyoka C, Poppe LK, Meinders K, et al
    High nonnucleoside reverse transcriptase inhibitor resistance levels in HIV-1-infected Zambian mother-infant pairs.
    AIDS. 2020;34:1833-1842.
    PubMed     Abstract available

    September 2020
  9. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.

    August 2020
  10. GAY CL, Neo DT, Devanathan AS, Kuruc JD, et al
    Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002652.
    PubMed     Abstract available

  11. INZAULE SC, Bertagnolio S, Kityo CM, Siwale M, et al
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS. 2020;34:1559-1566.
    PubMed     Abstract available

    July 2020
  12. GIATSOU E, Abdi B, Plu I, Desire N, et al
    Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy.
    AIDS. 2020 Jul 21. doi: 10.1097/QAD.0000000000002616.
    PubMed     Abstract available

  13. INZAULE SC, Jordan MR, Cournil A, Giron-Callejas A, et al
    Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002623.
    PubMed     Abstract available

    May 2020
  14. INZAULE SC, Jordan MR, Bello G, Wadonda-Kabondo N, et al
    High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly-diagnosed antiretroviral treatment naive children in sub-Saharan Africa.
    AIDS. 2020 May 20. doi: 10.1097/QAD.0000000000002580.
    PubMed     Abstract available

    March 2020
  15. PANPRADIST N, Beck IA, Ruth PS, Avila-Rios S, et al
    Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002524.
    PubMed     Abstract available

  16. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.

    December 2019
  17. YE J, Hao M, Xing H, Zhang F, et al
    Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: A multicenter observational study.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002468.
    PubMed     Abstract available

  18. SALOU M, Butel C, Comlan AS, Konou AA, et al
    Challenges of scale-up to Dolutegravir based regimens in sub-Saharan Africa: a case study in Togo.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002470.
    PubMed     Abstract available

    November 2019
  19. MORANGUINHO I, Borrego P, Goncalves F, Gomes P, et al
    Genotypic resistance profiles of HIV-2 infected patients from Cape Verde failing first-line antiretroviral therapy.
    AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002431.
    PubMed     Abstract available

    October 2019
  20. FOGEL JM, Sivay MV, Cummings V, Wilson EA, et al
    HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002394.
    PubMed     Abstract available

  21. LIU L, Dai L, Yao J, Pan P, et al
    Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China.
    AIDS. 2019;33:1945-1947.
    PubMed     Abstract available

    September 2019
  22. KOUAMOU V, Manasa J, Katzenstein D, McGregor AM, et al
    Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.
    AIDS. 2019;33:1729-1737.
    PubMed     Abstract available

    May 2019
  23. INZAULE SC, Mr J, Cournil A, Vitoria M, et al
    Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age: a double setback.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002277.
    PubMed     Abstract available

  24. AMBROSIONI J, Rico JAF, Nicolas D, Mosquera MM, et al
    E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection.
    AIDS. 2019 May 6. doi: 10.1097/QAD.0000000000002243.
    PubMed     Abstract available

  25. MOYO S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, et al
    Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
    AIDS. 2019;33:1073-1082.
    PubMed     Abstract available

  26. MILNE RS, Silverman RA, Beck IA, Mckernan-Mullin J, et al
    Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.
    AIDS. 2019;33:941-951.
    PubMed     Abstract available

    April 2019
  27. ALESSANDRI-GRADT E, Unal G, Leoz M, Plantier JC, et al
    Virological response to INSTI-based antiretroviral combinations in HIV-1 group O infected patients.
    AIDS. 2019 Apr 3. doi: 10.1097/QAD.0000000000002215.
    PubMed     Abstract available

    December 2018
  28. TODESCO E, Wirden M, Calin R, Simon A, et al
    Caution is needed in interpreting HIV transmission chains by ultra-deep sequencing.
    AIDS. 2018 Dec 21. doi: 10.1097/QAD.0000000000002105.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.